000 | 01900 a2200541 4500 | ||
---|---|---|---|
005 | 20250515204526.0 | ||
264 | 0 | _c20100920 | |
008 | 201009s 0 0 eng d | ||
022 | _a1755-3245 | ||
024 | 7 |
_a10.1093/cvr/cvq034 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOikawa, Ryo | |
245 | 0 | 0 |
_aDecreased susceptibility to salt-induced hypertension in subtotally nephrectomized mice lacking the vasopressin V1a receptor. _h[electronic resource] |
260 |
_bCardiovascular research _cJul 2010 |
||
300 |
_a187-94 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArginine Vasopressin _xadministration & dosage |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aHeart Rate |
650 | 0 | 4 |
_aHormone Antagonists _xadministration & dosage |
650 | 0 | 4 |
_aHypertension _xetiology |
650 | 0 | 4 | _aInjections, Intraventricular |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aNephrectomy |
650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-1 _xdeficiency |
650 | 0 | 4 |
_aReceptors, Vasopressin _xdeficiency |
650 | 0 | 4 |
_aSaline Solution, Hypertonic _xadministration & dosage |
650 | 0 | 4 |
_aSodium _xmetabolism |
650 | 0 | 4 |
_aSodium Chloride, Dietary _xadverse effects |
650 | 0 | 4 |
_aSympathetic Nervous System _xmetabolism |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aVasoconstriction |
700 | 1 | _aHosoda, Chihiro | |
700 | 1 | _aNasa, Yoshihisa | |
700 | 1 | _aDaicho, Takuya | |
700 | 1 | _aTanoue, Akito | |
700 | 1 | _aTsujimoto, Gozoh | |
700 | 1 | _aTakagi, Norio | |
700 | 1 | _aTanonaka, Kouichi | |
700 | 1 | _aTakeo, Satoshi | |
773 | 0 |
_tCardiovascular research _gvol. 87 _gno. 1 _gp. 187-94 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/cvr/cvq034 _zAvailable from publisher's website |
999 |
_c19490723 _d19490723 |